BRAINbox Solutions, Inc

IN THE PRESS

BioCapital

BRAINBox Solutions to Present Updated Data at Three Leading Conferences from HeadSMART II and NIH-funded Geriatrics Clinical Trials of BRAINBox TBI Concussion Test

March 4, 2024

·

5 min read

BioCapital

BRAINBox Solutions Announces Initial Series B Investments to Support U.S. Regulatory Clearance, Initial Commercialization of BRAINBox TBI Concussion Diagnostic/Prognostic Test

October 30, 2023

·

3 min read

BioCapital

USPTO Issues Notice of Allowance to BRAINBox Solutions to Grant Broad U.S. Patent Covering Biomarkers that Correlate to MRI Neuroimaging Findings

March 17, 2023

·

3 min read

BioCapital

BRAINBox Solutions Announces New U.S. Patent Allowance, Strengthening Biomarker Portfolio for Multi-Modal Mild Traumatic Brain Injury Test

October 4, 2022

·

4 min read

BioCapital

BRAINBox Solutions Awarded $3.5 Million NIH SBIR Grant to Develop Geriatric Specific Multi-Modality Diagnostic and Prognostic Testing System for mTBI (Concussion)

March 21, 2022

·

6 min read

BioCapital

BRAINBox Solutions Announces Enrollment Begins in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test

December 16, 2020

·

3 min read

BioCapital

BRAINBox Solutions Announces First Close in $23 Million in Series A Financing to Support Development and Pivotal Clinical Trial of ‘Breakthrough’ Concussion Diagnostic/Prognostic Test

December 8, 2020

·

4 min read

BioCapital

BRAINBox Solutions™ Receives Breakthrough Device Designation from FDA for First-of-Kind Device to Aid in Concussion Diagnosis and Prognosis

June 5, 2019

·

3 min read

JOBS